Search results
Oxford Nanopore Eyes TB Drug Resistance for First In-House-Developed Diagnostic Test
GenomeWeb News· 18 hours agoDubbed Ampore-TB, the assay will enable TB drug resistance profiling directly from sputum samples in about six hours using the GridIon platform and an automated analysis pipeline ...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond | The Motley Fool
The Motley Fool· 2 hours agoPer the research of Wharton professor Jeremy Siegel, stocks have outperformed bonds, gold, and the dollar over more than 200 years. Bonds were the closest competitor, but stocks beat bonds over ...
Some People Won't Be Able to Enroll in a Medigap Plan, or May Have to Pay More. Here's What You Need...
The Motley Fool via AOL· 36 minutes agoYou'll need to choose between original Medicare and a Medicare Advantage plan as you approach age...
Biocon and Handok link to commercialise Liraglutide in South Korea
Pharmaceutical Technology via Yahoo Finance· 4 hours agoIndian biopharmaceutical company Biocon has entered an exclusive licence and supply agreement with...
FDA Panel Gives Nod to Blood Test for Colon Cancer
Homenewshere.com· 1 hour agoA U.S. Food and Drug Administration advisory panel on Thursday recommended the approval of a new blood test that can spot colon cancer. The panel voted 7-2 that the benefits ...
8 people have sued Sean 'Diddy' Combs for sexual assault in 5 months. Here's a timeline of the...
Business Insider via Yahoo News· 2 hours agoPierre didn't immediately respond to a request for comment. On February 20, 2024, Rolling Stone...
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 1 hour agoShares in the company rose 40% in premarket trading. Patients in the dose level I cohort received...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters via Yahoo News· 3 hours agoThe company in March reported that the diabetes drug known chemically as semaglutide cut the...
Bayer Calls Roundup Suits Existential Threat to Company, Farming
Bloomberg via Yahoo Finance· 5 hours ago(Bloomberg) -- Bayer AG Chief Executive Officer Bill Anderson said the wave of lawsuits over its...
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
InvestorPlace· 1 day agoFor investors looking at companies providing GLP-1 drugs, there are certainly plenty of factors to...
